Jason Kim is CEO of Hyundai ADM Bio and Hyundai Bioscience USA, fully-owned subsidiaries of Hyundai Bioscience. He also served as a board member and EVP of Business Development at Hyundai Bioscience for many years. He graduated from Yonsei University with a Bachelor of Laws and lives in Orange County, California. Jason Kim spearheads Hyundai Bioscience’s efforts to expand its footprint in the global biopharmaceutical market, overseeing strategic initiatives aimed at innovative therapeutics, particularly in oncology and antiviral treatments. His strategic vision and dedication to fostering global partnerships have been pivotal in driving the company’s growth on the international stage. He remains committed to promoting scientific collaboration and innovation, ensuring Hyundai Bioscience and its affiliates continue to contribute meaningfully to global healthcare advancements.